Logan Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
+258,642
New +$11.6M 0.41% 59
2026
Q1
Sell
-147,363
Closed -$6.87M 490
2025
Q4
$7.14M Buy
147,363
+14,376
+11% +$713K 0.3% 93
2025
Q3
$6.28M Buy
132,987
+16,772
+14% +$809K 0.26% 100
2025
Q2
$5.61M Buy
116,215
+28,436
+32% +$1.45M 0.26% 101
2025
Q1
$4.87M Buy
87,779
+2,479
+3% +$134K 0.22% 111
2024
Q4
$4.11M Buy
85,300
+111
+0.1% +$5.64K 0.17% 123
2024
Q3
$4.91M Buy
85,189
+3,774
+5% +$204K 0.2% 117
2024
Q2
$3.95M Sell
81,415
-3,243
-4% -$156K 0.17% 129
2024
Q1
$4.11M Buy
84,658
+13,399
+19% +$654K 0.18% 130
2023
Q4
$3.54M Buy
71,259
+2,356
+3% +$115K 0.17% 136
2023
Q3
$3.7M Buy
68,903
+3,739
+6% +$199K 0.19% 128
2023
Q2
$3.51M Sell
65,164
-1,957
-3% -$105K 0.17% 134
2023
Q1
$3.65M Buy
67,121
+332
+0.5% +$16.1K 0.18% 131
2022
Q4
$3.23M Buy
66,789
+2,403
+4% +$105K 0.17% 138
2022
Q3
$2.45M Buy
64,386
+5,493
+9% +$245K 0.15% 136
2022
Q2
$2.95M Buy
58,893
+7,648
+15% +$406K 0.17% 131
2022
Q1
$2.63M Buy
51,245
+3,137
+7% +$162K 0.13% 147
2021
Q4
$2.41M Buy
48,108
+6,682
+16% +$331K 0.1% 159
2021
Q3
$2M Buy
41,426
+490
+1% +$24.9K 0.09% 157
2021
Q2
$2.16M Buy
40,936
+4,107
+11% +$214K 0.1% 154
2021
Q1
$1.82M Buy
36,829
+1,044
+3% +$50.2K 0.09% 156
2020
Q4
$1.74M Sell
35,785
-1,846
-5% -$91K 0.09% 159
2020
Q3
$1.89M Buy
37,631
+2,180
+6% +$112K 0.1% 185
2020
Q2
$1.81M Buy
35,451
+1,395
+4% +$67.8K 0.1% 142
2020
Q1
$1.49M Buy
34,056
+1,055
+3% +$50.5K 0.1% 158
2019
Q4
$1.66M Buy
33,001
+484
+1% +$22.7K 0.09% 158
2019
Q3
$1.51M Buy
32,517
+3,065
+10% +$132K 0.09% 161
2019
Q2
$1.27M Buy
29,452
+3,047
+12% +$130K 0.07% 172
2019
Q1
$1.17M Sell
26,405
-2,592
-9% -$111K 0.07% 174
2018
Q4
$1.26M Buy
28,997
+674
+2% +$29.7K 0.1% 142
2018
Q3
$1.26M Sell
28,323
-864
-3% -$36.9K 0.08% 153
2018
Q2
$1.17M Buy
29,187
+3,597
+14% +$142K 0.08% 157
2018
Q1
$1.03M Buy
25,590
+213
+0.8% +$8.86K 0.07% 166
2017
Q4
$1.09M Buy
25,377
+4,497
+22% +$207K 0.08% 160
2017
Q3
$1.04M Buy
20,880
+1,785
+9% +$86.4K 0.07% 160
2017
Q2
$915K Buy
19,095
+294
+2% +$14.1K 0.07% 167
2017
Q1
$851K Sell
18,801
-2,373
-11% -$101K 0.07% 174
2016
Q4
$856K Sell
21,174
-83
-0.4% -$3.27K 0.07% 183
2016
Q3
$812K Buy
21,257
+1,723
+9% +$69.1K 0.07% 180
2016
Q2
$818K Buy
19,534
+1,904
+11% +$78.1K 0.07% 166
2016
Q1
$708K Buy
17,630
+1,411
+9% +$56.7K 0.06% 201
2015
Q4
$691K Buy
16,219
+162
+1% +$7.45K 0.06% 201
2015
Q3
$762K Sell
16,057
-433
-3% -$22K 0.06% 176
2015
Q2
$816K Buy
16,490
+1,396
+9% +$70.7K 0.06% 181
2015
Q1
$747K Buy
15,094
+1,811
+14% +$86.6K 0.05% 187
2014
Q4
$606K Buy
13,283
+2,127
+19% +$103K 0.04% 205
2014
Q3
$629K Sell
11,156
-503
-4% -$27K 0.05% 183
2014
Q2
$620K Buy
11,659
+1,552
+15% +$82.4K 0.04% 183
2014
Q1
$528K Buy
10,107
+725
+8% +$36.7K 0.04% 197
2013
Q4
$503K Buy
9,382
+167
+2% +$8.62K 0.04% 199
2013
Q3
$466K Buy
9,215
+837
+10% +$42.6K 0.03% 191
2013
Q2
$317K Buy
+8,378
New +$446K 0.03% 202

Other funds holding SNY

Logan Capital Management's SNY Position: Q2 2026 in Review

Logan Capital Management opened a new position in Sanofi (SNY) in Q2 2026: 258,642 shares worth $11M. The stake represents 0.41% of the portfolio and ranks #59 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in SNY as recently as Q4 2025.

Logan Capital Management first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Logan Capital Management held 258,642 shares of Sanofi worth $11M as of Q2 2026.
  • Sanofi was a new Logan Capital Management position in Q2 2026.
  • Sanofi made up 0.41% of Logan Capital Management's portfolio in Q2 2026, its #59 holding.
  • Logan Capital Management first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.